Marco, D.N.; Salas, M.Q.; Gutiérrez-García, G.; Monge, I.; Riu, G.; Carcelero, E.; Roma, J.R.; Llobet, N.; Arcarons, J.; Suárez-Lledó, M.;
et al. Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide. Pharmaceuticals 2022, 15, 1529.
https://doi.org/10.3390/ph15121529
AMA Style
Marco DN, Salas MQ, Gutiérrez-García G, Monge I, Riu G, Carcelero E, Roma JR, Llobet N, Arcarons J, Suárez-Lledó M,
et al. Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide. Pharmaceuticals. 2022; 15(12):1529.
https://doi.org/10.3390/ph15121529
Chicago/Turabian Style
Marco, Daniel N., María Queralt Salas, Gonzalo Gutiérrez-García, Inés Monge, Gisela Riu, Esther Carcelero, Joan Ramón Roma, Noemí Llobet, Jordi Arcarons, María Suárez-Lledó,
and et al. 2022. "Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide" Pharmaceuticals 15, no. 12: 1529.
https://doi.org/10.3390/ph15121529
APA Style
Marco, D. N., Salas, M. Q., Gutiérrez-García, G., Monge, I., Riu, G., Carcelero, E., Roma, J. R., Llobet, N., Arcarons, J., Suárez-Lledó, M., Martínez, N., Pedraza, A., Domenech, A., Rosiñol, L., Fernández-Avilés, F., Urbano-Ispízua, Á., Rovira, M., Brunet, M., & Martínez, C.
(2022). Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide. Pharmaceuticals, 15(12), 1529.
https://doi.org/10.3390/ph15121529
